-
news
-
Health
Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesity
Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirazepateide, in India by 2025, which will be marketed under the Monjaro and Zepbound brands. Proposed dosages range from 2.5 mg to 15 mg. Read on to know more about the medicine and how it helps in weight loss.
The company has received marketing authorization from the relevant authorities for both type 2 diabetes and obesity indications
US pharma giant Eli Lilly plans to bring its obesity and diabetes drug tirazepate or Monzaro to India next year and has said it will price it “competitively and appropriately”. According to news reports, the company has received marketing authorization from the relevant authorities for both. Signs of type 2 diabetes and obesity.
“We aim to launch tirazeptide in India by 2025, after receiving other pending necessary regulatory approvals,” the spokesperson said. Business Standard.
“While we have not yet finalized the price of tirazepitide for India, Lilly is committed to ensuring that tirazepitide remains accessible to patients who need it. Our pricing strategy for tirazeptide in India will be competitive and appropriate, reflecting the drug’s efficacy and significant value in reducing the overall health and economic burden of type 2 diabetes and obesity.
How does Monjaro work for diabetes and obesity,
According to experts, obesity is a chronic disease – a metabolic dysfunction that affects your body down to the cellular level. Although it is important to exercise regularly and eat healthy, these steps alone do not fully help people with obesity achieve a healthy weight and increase their risk for other chronic conditions such as heart disease, diabetes and fatty liver disease. Do not minimize the risk.
And hence, diabetes medicines like Monjaro have immense effect in weight loss.
What is Monjaro?
monjaro is one Injectable medicine to treat type 2 diabetes And is available by prescription only. Experts say it works by targeting two hormones:
- GLP-1, which is released from your digestive system, helps lower blood sugar and promotes feelings of fullness.
- Glucose-dependent insulinotropic polypeptide – which stimulates the release of insulin.
Doctors say the drug changes your body’s response to food. It makes you feel full faster and changes your blood sugar levels, making it an extremely powerful tool to manage both diabetes and obesity.
monjaro for weight loss
Even though it is primarily a diabetes medicine, Monjaro helps significantly in reducing weight in obese people. Many studies and research say that this medicine is similar to another popular diabetes medicine, Ozempic, which has become popular worldwide for its weight loss effects. Ozempic is known by the generic name semaglutide.
Should you take Monjaro?
According to doctors, if you want to lose weight quickly for an event then you should avoid Monjaro. But if you’re living with diabetes or obesity, it’s worth a try. Your doctor will also recommend diet and exercise along with medication.
Also, since this is a long-term treatment, when you stop taking the medication, there are chances that your lost weight will come back again. Therefore, it is always best to discuss with a doctor who understands obesity how these medications work and what you should expect.
Get the latest news live on Times Now with breaking news and top headlines from around the world.